Get the Stockscreener App
1.01
3.81%
-0.04
Pre-market:
1.00
-0.01
-0.99%
Canopy Growth Corporation stock is traded at $1.01, with a volume of 29.53M.
It is down -3.81% in the last 24 hours and down -27.34% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.05
Open:
$1.08
24h Volume:
29.53M
Relative Volume:
1.26
Market Cap:
$315.11M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.148
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-8.18%
1M Performance:
-27.34%
6M Performance:
-42.94%
1Y Performance:
-73.14%
1-Day Range:
$1.01
$1.11
1-Week Range:
$1.01
$1.12
52-Week Range:
$0.77
$4.2472
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.01 | 359.31M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
StockTalk | Cannabis Report: Growing the product reach | 2025-11-21 | Investing News - Stockhouse
How Canopy Growth Corporation (11L) stock gains from tech spendingJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Cannabis Stocks To ConsiderNovember 20th - MarketBeat
Price action breakdown for Canopy Growth CorporationJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Is Canopy Growth Corporation stock a safe haven assetWall Street Watch & Expert Curated Trade Ideas - newser.com
Canopy Growth No Longer A Strong Sell (NASDAQ:CGC) - Seeking Alpha
How high can Canopy Growth Corporation stock goWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com
Is Canopy Growth Corporation meeting your algorithmic filter criteriaMarket Trend Report & Growth-Oriented Investment Plans - newser.com
Why Canopy Growth Corporation (11L) stock is a must watch tickerWatch List & Daily Chart Pattern Signals - newser.com
Will Canopy Growth Corporation (11L) stock benefit from commodity supercycleJuly 2025 Rallies & Low Drawdown Momentum Ideas - newser.com
Why Canopy Growth Corporation stock could outperform in 2025July 2025 Action & Smart Allocation Stock Tips - newser.com
How Canopy Growth Corporation (11L) stock performs in volatility spikesAnalyst Upgrade & AI Based Buy and Sell Signals - newser.com
What makes Canopy Growth Corporation stock attractive to growth funds - newser.com
Volatility clustering patterns for Canopy Growth CorporationTrade Volume Summary & Daily Chart Pattern Signals - newser.com
What downside risks could hit Canopy Growth Corporation (11L) stockPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Measuring Canopy Growth Corporation’s beta against major indicesQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Is Canopy Growth Corporation stock attractive for retirement portfoliosJuly 2025 Action & Community Consensus Picks - newser.com
Best Cannabis Stocks Worth WatchingNovember 18th - MarketBeat
Growth Stocks To Keep An Eye OnNovember 17th - MarketBeat
Stocks in play: Canopy Growth Corporation - The Globe and Mail
Canopy Growth expands Australian medical cannabis product suite | 2025-11-18 | Investing News - Stockhouse
Canopy Growth Rolls Out New Medical Cannabis Softgels In Australia - Finimize
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels - Bluefield Daily Telegraph
Cannabis Stocks To Watch TodayNovember 17th - MarketBeat
Cannabis Stocks To Watch NowNovember 2nd - MarketBeat
Analyzing net buyer seller activity in Canopy Growth Corporation2025 Technical Patterns & Consistent Income Trade Recommendations - newser.com
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):